Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
User's guide to mechanism of action and clinical use of GLP-1 receptor agonists
HL: Conceptualization, Writing review & editing
Rather than being manufactured under a brand name, it is prepared by a state-licensed compounding pharmacy pursuant to a prescription
The company said it has helped more than 2 million people to navigate their benefits, reinforcing its positioning as both a care provider and access facilitator in a category where pricing and reimbursement remain key friction points.
Injectable drugs used for weight loss are fueling a frenzy right now, but high demand is putting a strain on availability
The state Office of the Health Insurance Commissioner wrote in a report in May that spending on GLP-1s such as Ozempic, Weygovy, Mounjaro and Zepbound "nearly tripled" from 2021 to 2023 and was the "primary driver" behind a 7.8% increase in total health care spending in 2023
US$ 26.36
US$ 29.70
US$ 26.60
US$ 23.04
US$ 26.14
US$ 20.47
US$ 21.96
